AzTrials
AzTrials

Child DevelopmentNCT05197998

Leveraging Families to Promote Healthy Socio-Emotional Development in Children

A study testing ColorBRAVE in people with Child Development and Parents, run by Tulane University at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The objective of this research is to evaluate a mobile app-based intervention for parents of children in K-2nd grade designed that guides them in how to have productive conversations about race with their children. This study will recruit a national sample of parents and their K-2nd grade children. Read more about this study

Who is it for?
Ages 5 to 100 yearsHealthy volunteers can take part
What is being tested?
ColorBRAVE
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,200 participants
Where
1 siteUnited States
Study dates
1 Feb 2027to 31 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Residence in the US; caregiver age 18 years or older and child age 5-8 years old; ability to read and understand English

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

David H. Chae, ScD, MA contact

504-988-1847

dchae@tulane.edu

United States1 site
  • Tulane University

    New Orleans, Louisiana, 70112

    David H. Chae, ScD MA, 504-988-1847, dchae@tulane.edu

Other trials in United States

About this study

The objective of this research is to evaluate a mobile app-based intervention for parents of children in K-2nd grade designed that guides them in how to have productive conversations about race with their children. This study will recruit a national sample of parents and their K-2nd grade children. The impact of the intervention is tested using a wait-list controlled trial design. Outcomes include prosocial behaviors and indicators of emotional well-being.

Being tested
ColorBRAVE

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ColorBRAVEBehavioural

    The intervention is a multi-module program delivered via a mobile app for parents of children in K-2nd grade. Each module in the program will take approximately 30 minutes to complete, with lessons facilitated through interactive storytelling, videos, and games.

Study groups in NCT05197998
Study groupRoleWhat they receive
ColorBRAVEExperimentalThe experimental group will be asked to download a multi-module mobile app designed to guide parents and caregivers in having conversations about race with their K-2nd grade children
Receives: Behavioral: ColorBRAVE
Wait-list ControlOtherThe wait-list control group will be placed on the wait-list for the first 6-weeks, the period in which the experimental group will complete the intervention program. Following the 6-week wait-list period they will receive the ColorBRAVE program.
Receives: Behavioral: ColorBRAVE

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Racial Socialization Frequency Scale

    Parents will report the frequency with which they engage in racial socialization practices with their K-2nd grade child.

    Measured: 0-12 months

  2. Racial Socialization Competency Scale

    Parents will report the degree of comfort, skills, and stress in engaging in different processes related to racial socialization with their K-2nd grade child.

    Measured: 0-12 months

  3. Cross-race Friendships

    Parents will report the race of their K-2nd grade child's 5 closest friends - the number of cross-race friendships will consist of the number of friends that are race discordant to their child.

    Measured: 0-12 months

  4. Colorblind Racial Attitudes (CoBRAS) Scale

    Color-blind racial attitudes among parents will be assessed using the COBRAS Scale.

    Measured: 0-12 months

  5. Child Prosocial Behavior Questionnaire (CPBQ)

    Parents will report on the degree to which their K-2nd grade child engages in various prosocial behaviors, including those surrounding helping, sharing, and comforting.

    Measured: 0-12 months

  6. Patient-Reported Outcomes Measurement Information System (PROMIS) Parent Proxy Measures

    Parent reports of child socio-emotional well being (e.g., positive peer relationships, depression, anxiety).

    Measured: 0-12 months

  7. Prosocial Children Measure

    Children (ages 5-8 years old) will be introduced to a child and told scenarios in which that child must choose other children to engage in various activities with, among a group of diverse children. Children will be asked (1) whether they liked or disliked how that child chose the children to participate in the activity with and (2) if there is anything they would like to say to that child about their choice in children.

    Measured: 0-12 months

  8. Child Bystander Response Questionnaire

    Children will report the frequency with which they engage in different bystander behaviors when they see someone being treated poorly or unfairly due to their race, ethnicity, or cultural background.

    Measured: 0-12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jan 2022
  2. Study start1 Feb 2027 (estimated)
  3. Primary completion31 May 2027 (estimated)
  4. Study completion31 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Wait-list control design
Masking
None (open label)
Enrolment
1,200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05197998
Sponsor's protocol ID
5U01HD115257-04
Other IDs
5U01HD115257-04
Status last verified
Oct 2026
First submitted
22 Nov 2021
Last updated
26 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Upon completion of key analyses, study documentation and de-identified data will be made available to the research community upon request. Data requests may be submitted to the Project Coordinator and reviewed by the study PI to determine whether there is significant scientific overlap in the research questions and analyses proposed by the outside investigator. Those who submit qualified proposals will be provided with a dataset containing only the variables requested and the associated documentation (e.g., codebooks, description of study protocols, data dictionaries) under a data sharing agreement.

Questions about this trial

What is this clinical trial studying?

A study testing ColorBRAVE in people with Child Development and Parents, run by Tulane University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact David H. Chae, ScD, MA (504-988-1847, dchae@tulane.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Racial Socialization Frequency Scale (time frame: 0-12 months). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in